Variant report
Variant | nsv1051026 |
---|---|
Chromosome Location | chr11:24214723-24260429 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-17A1.2.1-3 | chr11:24257023-24257051 | ENSG00000254594 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553337365 | chr11:24216437-24216438 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113322540 | chr11:24216462-24216463 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7933418 | chr11:24216464-24216465 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs147142714 | chr11:24216468-24216469 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190971833 | chr11:24216546-24216547 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573127013 | chr11:24216551-24216552 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575122580 | chr11:24216567-24216568 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540531926 | chr11:24216596-24216597 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567205527 | chr11:24219813-24219814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376531661 | chr11:24219815-24219816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560540493 | chr11:24219848-24219849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564618937 | chr11:24219866-24219867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74782867 | chr11:24219893-24219894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542089624 | chr11:24219894-24219895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190494631 | chr11:24219899-24219900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535311519 | chr11:24219911-24219912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75738228 | chr11:24219949-24219950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs578253719 | chr11:24219960-24219961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576719920 | chr11:24220006-24220007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537400831 | chr11:24220017-24220018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373083507 | chr11:24220065-24220066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370137085 | chr11:24220111-24220112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7942689 | chr11:24220130-24220131 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs574041415 | chr11:24220146-24220147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543140984 | chr11:24220197-24220198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114386202 | chr11:24220206-24220207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144801572 | chr11:24220214-24220215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370099457 | chr11:24220233-24220234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544817076 | chr11:24220234-24220235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183750526 | chr11:24220256-24220257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530715272 | chr11:24220276-24220277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186871927 | chr11:24220299-24220300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191348840 | chr11:24220302-24220303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572452321 | chr11:24220332-24220333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529741167 | chr11:24220346-24220347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546704761 | chr11:24220361-24220362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183172577 | chr11:24220377-24220378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186638517 | chr11:24220379-24220380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191288133 | chr11:24220394-24220395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552013504 | chr11:24220409-24220410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571922620 | chr11:24220418-24220419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537794958 | chr11:24220463-24220464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557063287 | chr11:24220506-24220507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567677717 | chr11:24220519-24220520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536271723 | chr11:24220555-24220556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556536975 | chr11:24220563-24220564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183089617 | chr11:24220578-24220579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12286254 | chr11:24220579-24220580 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs76120858 | chr11:24220597-24220598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12273122 | chr11:24220599-24220600 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:24216400-24216600 | ZNF genes & repeats | Right Atrium | heart |
2 | chr11:24219800-24220400 | Enhancers | Placenta Amnion | Placenta Amnion |
3 | chr11:24220000-24220600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr11:24236200-24237000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr11:24248200-24248600 | Enhancers | HepG2 | liver |
6 | chr11:24248200-24249000 | Enhancers | Stomach Mucosa | stomach |
7 | chr11:24248400-24249000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr11:24255600-24257000 | Enhancers | Stomach Mucosa | stomach |
9 | chr11:24255800-24257000 | Enhancers | Gastric | stomach |
10 | chr11:24256200-24256800 | Enhancers | Pancreas | Pancrea |
11 | chr11:24256200-24257200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr11:24256400-24256600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr11:24256400-24257000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr11:24257200-24260200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr11:24259800-24262800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr11:24259800-24262800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
17 | chr11:24260200-24261800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
18 | chr11:24260400-24261400 | Enhancers | Colon Smooth Muscle | Colon |